Thus, compared to exosome-treated controls, the expression and activities of the tested cell cycle regulatory proteins in the two cancer cell lines (MCF-7 and MDA-MBA231) were found to be reduced by the treatment with both preparations of sEV (Figure 6B). The gene discussed is RCC1; the disease is cancer.